摘要
对于不能手术的胸腺瘤患者常采用放疗、化疗、免疫治疗及靶向治疗等非手术治疗或综合治疗。对于局部晚期胸腺瘤,首选手术治疗,术后辅助放化疗;不能手术的患者可先行诱导治疗,再予以手术治疗和术后辅助放化疗。目前,胸腺瘤尚无统一的治疗标准,临床还处于研究探索阶段。本研究就胸腺瘤非手术治疗的预后进行综述,以期为临床治疗提供参考。
Thymoma of non-surgical treatment or combined modality therapy must be considered in advanced or unresectable cases, which includes radiotherapy, chemotherapy, targeted therapy and immunotherapy. The first choice of reseetable advanced thymoma is surgery followed by adjuvant radiotherapy or chemotherapy. For unrcsectable advanced thymoma, inducted therapy followed by surgery and adjuvant therapy is a rational pattern. But the best treatment mode is still unclear. We review the effect and prognosis about non-surgical treatment of thymoma recent years, to offer advice about making the best decision in the treatment of thymoma.
作者
王晓丹
冯勤付
Wang Xiaodan;Feng Qingfu(Departments of Radiation Oncology, National Cancer Center/Cancer Hospital/Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China)
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2018年第6期607-611,共5页
Chinese Journal of Radiation Oncology